Online citations, reference lists, and bibliographies.
← Back to Search

Effects Of Postoperative Mediastinal Radiation On Completely Resected Stage II And Stage III Epidermoid Cancer Of The Lung.

T. Weisenburger, M. Gail
Published 1986 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We randomly assigned 230 patients with resected Stage II or III epidermoid (squamous-cell) lung cancer to receive postoperative adjuvant radiotherapy or no adjuvant treatment. Careful intraoperative staging had been performed in all patients. Before randomization, patients were stratified according to stage, weight loss, age, and institution. Prognostic variables, such as stage, weight loss, age, nodal-disease status, and tumor status, were equally distributed between the two groups. The mean time from randomization to analysis was 3.5 years among the 210 eligible patients. There was no evidence that radiotherapy improved survival, and although recurrence rates appeared to be somewhat reduced among patients assigned to radiotherapy, these decreases were not statistically significant. However, radiotherapy did produce a striking and significant reduction in recurrences to the ipsilateral lung and mediastinum. Moreover, overall recurrence rates were reduced by radiotherapy in patients with N2 disease (P less than 0.05), although even this subgroup had no evidence of improved survival. We conclude that radiotherapy can reduce local recurrences after resection of epidermoid carcinoma of the lung, but that it does not increase survival rates.



This paper is referenced by
10.1016/S0936-6555(96)80041-0
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
F. Macbeth (1996)
10.1016/0169-5002(95)00515-3
Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992.
M. Debevec (1996)
10.1016/S0169-5002(98)00073-7
Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patients.
N. Katakami (1998)
10.1378/CHEST.116.1.144
Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
I. Yoshino (1999)
10.1016/0003-4975(93)90131-Z
Postoperative complications after combined neoadjuvant treatment of lung cancer.
W. Fowler (1993)
10.1002/1097-0142(19890901)64:5<1021::AID-CNCR2820640509>3.0.CO;2-0
Concomitant 5‐fluorouracil infusion and high‐dose radiation for stage III non‐small cell lung cancer
J. Lokich (1989)
10.1016/S0003-4975(10)64545-6
Carcinoma of the lung.
E. Holmes (1988)
10.1016/j.lungcan.2010.06.001
Local failure after complete resection of N0-1 non-small cell lung cancer.
M. Saynak (2011)
10.1016/j.lungcan.2013.02.005
A closer look at the effects of postoperative radiotherapy by stage and nodal status: updated results of an individual participant data meta-analysis in non-small-cell lung cancer.
S. Burdett (2013)
10.1016/j.semradonc.2010.01.008
Current status of postoperative radiation for non-small-cell lung cancer.
M. Saynak (2010)
10.1378/CHEST.128.4.2933
Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer.
A. Visbal (2005)
10.1081/CNV-67172
State of the Art in Therapy for Non-Small Cell Lung Cancer
J. Laskin (2005)
10.1016/S0169-5002(01)00296-3
Principles of surgical treatment in localized non-small cell lung cancer.
H. Dienemann (2001)
10.1016/S0360-3016(00)01401-2
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach.
S. Tyldesley (2001)
10.1007/978-3-642-72041-3_14
Radiotherapie des Bronchialkarzinoms
P. Schraube (1998)
10.1007/s11864-009-0090-8
Post-Operative Radiation Therapy (PORT) in Completely Resected Non-Small-Cell Lung Cancer
Y. Krupitskaya (2008)
Lung cancer v 5 : State of the art radiotherapy for lung cancer
A. Price (2003)
10.1097/00000421-199902000-00003
Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer.
E. Baldini (1999)
10.1002/JSO.2930590303
Neoadjuvant chemotherapy of stage III‐A and B lung carcinoma using the pacco regimen
H. Takita (1995)
10.1007/978-3-540-69886-9_16
CyberKnife frameless Image-Guided high-dose fractionated stereotactic radiosurgery with the synchrony motion tracking module in the treatment of single small peripheral lung tumors
B. Collins (2007)
10.1378/chest.09-0868
Survival following sublobar resection for early-stage non-small cell lung cancer with or without adjuvant external beam radiation therapy: a population-based study.
J. Rineer (2010)
10.18907/JJSRE.21.8_566
肺野末梢小型肺腺癌の質的診断と治療(肺野末梢微小肺癌 : 診断と治療の展開)(第 22 回日本気管支学会総会)
健司 鈴木 (1999)
10.5306/wjco.v8.i1.1
Therapeutic management options for stage III non-small cell lung cancer
S. Yoon (2017)
10.1007/978-1-60761-524-8_6
Adjuvant and Neoadjuvant Therapy of NSCLC
Katherine M. W. Pisters (2010)
10.1016/j.rmed.2011.05.013
Clinical value of detection of metastasis of carina in patients with non-small cell lung cancer.
Hasan Kaynar (2011)
10.1016/j.ctrv.2011.11.008
Adjuvant immunotherapy for non-small cell lung cancer.
Zachary C. G. Tucker (2012)
10.1016/S0360-3016(03)00743-0
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
I. Grills (2003)
10.5694/j.1326-5377.1989.tb136428.x
Lung cancer in Australia
G. McLennan (1989)
10.1097/01.smj.0000177344.48950.65
Late Stage (III and IV) Non-small Cell Cancer of the Lung: Results of Surgical Resection at Inova Fairfax Hospital
P. D. Kiernan (2005)
10.1245/ASO.2006.01.015
Chemotherapy and Radiotherapy in the Treatment of Resectable Non–Small-Cell Lung Cancer
E. Bernstein (2006)
10.1007/S11748-003-0047-Y
Prognostic significance of persistent mediastinal metastasis following induction therapy in large (> or = 2 cm) N2 or N3 non-small cell lung cancer.
N. Sawabata (2003)
10.1378/CHEST.114.2.593
Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer.
E. Perez (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar